14 drug(s) with this reaction
44,571 total reports
Abdominal Pain has been reported as an adverse reaction across 14 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 44,571 adverse event reports mention abdominal pain in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with abdominal pain, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have abdominal pain listed in their FDA adverse event reports, sorted by report count:
In addition to abdominal pain, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
14 drug(s) manufactured by Abbvie Inc have abdominal pain listed in their FDA adverse event reports: Humira, ADALIMUMAB, LEVOTHYROXINE SODIUM, PANCRELIPASE, FENOFIBRATE, and others.
There are a combined 44,571 reports of abdominal pain across 14 Abbvie Inc drug(s) in the FDA adverse event database.